<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03543371</url>
  </required_header>
  <id_info>
    <org_study_id>CardiacArrestLundNeuropsych</org_study_id>
    <nct_id>NCT03543371</nct_id>
  </id_info>
  <brief_title>Neuropsychological Outcome After Cardiac Arrest</brief_title>
  <official_title>Neuropsychological Outcome After Cardiac Arrest: A Prospective Case Control Sub-study of the Targeted Hypothermia Versus Targeted Normothermia After out-of Hospital Cardiac Arrest Trial (TTM2)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Halmstad County Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mid and South Essex NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cardiff and Vale University Health Board</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a sub-study to the large pragmatic Target Temperature Management 2 Trial&#xD;
      (TTM2-trial, ClinicalTrials.gov Identifier: NCT02908308), assessing effectiveness of&#xD;
      controlled hypothermia after out-of-hospital cardiac arrest (OHCA).&#xD;
&#xD;
      This study is designed to provide detailed information on cognition after OHCA and its&#xD;
      relationship to associated factors as emotional function, fatigue, and sleep. A secondary aim&#xD;
      is to utilize this information to validate a neurocognitive screening battery used 6 months&#xD;
      after OHCA in the TTM2-trial.&#xD;
&#xD;
      Approximately 7 and 24 months after OHCA, survivors at selected TTM2 study sites will perform&#xD;
      a standardized neuropsychological assessment including performance-based tests of cognition&#xD;
      and questionnaires of behavioral and emotional function, fatigue, and insomnia. At 1:1 ratio,&#xD;
      a control group of myocardial infarction (MI) patients but no occurrence of cardiac arrest&#xD;
      will be recruited and perform the same test battery. Group differences at 7 and 24 months&#xD;
      will be analyzed per cognitive domain (verbal, visual/constructive, short-term working&#xD;
      memory, episodic memory, processing speed, executive functions). Results of the OHCA&#xD;
      survivors on the TTM2 neurocognitive screening battery will be compared with&#xD;
      neuropsychological test results at 7 months time.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 13, 2018</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Actual">January 11, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cognitive impairment</measure>
    <time_frame>7 months after the cardiac event</time_frame>
    <description>Cognitive function in OHCA and MI patients, using composite z-scores from the neuropsychological tests grouped by cognitive domain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and specificity of the neurocognitive screening battery in the main TTM2-trial</measure>
    <time_frame>7 months post-arrest</time_frame>
    <description>Validation of the neurocognitive screening battery in OHCA patients, using the detailed neuropsychological test battery as a gold standard with sensitivity and specificity analyses. Here, patients will be considered to have a cognitive impairment if they meet any of the following criteria on the neuropsychological tests: 1) an impaired composite z-score defined as z ≤ - 1.65 in at least one cognitive domain; 2) z ≤ - 1.65 in at least two scores used for cognitive domain calculation. Cut-scores for indicated impairment on the neurocognitive screening battery will be &lt; 26 on the MoCA, z≤-1 on the SDMT, ≥3.08 on the IQCODE-CA and the answer &quot;no&quot; to question 2 at the TSQ.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in cognitive function</measure>
    <time_frame>7 months, 24 months after the cardiac event</time_frame>
    <description>Longitudinal change in cognitive function in OHCA and MI patients, analyzed with a mixed model regression.</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Heart Arrest, Out-Of-Hospital</condition>
  <condition>Hypoxia-Ischemia, Brain</condition>
  <condition>Cognition Disorders</condition>
  <condition>Psychological Distress</condition>
  <condition>Fatigue</condition>
  <condition>Insomnia</condition>
  <arm_group>
    <arm_group_label>Cardiac Arrest survivors</arm_group_label>
    <description>Cardiac arrest survivors at selected TTM2-sites only.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Myocardial Infarction patients</arm_group_label>
    <description>A control group from a cohort of patients with myocardial infarction with performed coronary angiography but no occurrence of cardiac arrest will be recruited at 1:1 ratio.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Neuropsychological assessment</intervention_name>
    <description>Standardized neuropsychological battery consisting of the following tests and questionnaires: Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV) Vocabulary, Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency, WAIS-IV Block Design, WAIS-IV Matrix Reasoning, WAIS-IV Digit Span, Wechsler Memory Scale - Third Edition (WMS-III) Spatial Span, Rey Auditory Verbal Learning Test (RAVLT), WMS-III Logical Memory, Brief Visuospatial Memory Test-Revised (BVMT-R), Trail Making Test (TMT) A &amp; B, D-KEFS Color Word Interference Test, Behavioral Assessment of the Dysexecutive Syndrome Dysexecutive Questionnaire (BADS DEX), Multidimensional Fatigue Inventory (MFI-20), Minimal Insomnia Symptom Scale (MISS), Hospital Anxiety and Depression Scale (HADS).</description>
    <arm_group_label>Cardiac Arrest survivors</arm_group_label>
    <arm_group_label>Myocardial Infarction patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        OHCA survivors at TTM2-sites participating in this study. Survivors are invited to partake&#xD;
        in this study at the regular six-month follow-up of the TTM2-trial.&#xD;
&#xD;
        The cohort of MI patients acting as controls are recruited and assessed at one&#xD;
        participating site per country through quality registers.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  OHCA of a presumed cardiac or unknown cause (OHCA cohort only)&#xD;
&#xD;
          -  Sustained return of spontaneous circulation (ROSC) during intensive care - defined as&#xD;
             20 minutes with signs of circulation without the need for chest compressions (OHCA&#xD;
             cohort only)&#xD;
&#xD;
          -  Unconsciousness - defined as not being able to obey verbal commands (FOUR-score motor&#xD;
             response of &lt;4) and no verbal response to pain after sustained ROSC (OHCA cohort only)&#xD;
&#xD;
          -  Inclusion within 180 minutes of ROSC (OHCA cohort only)&#xD;
&#xD;
          -  During intensive care - eligible for intensive care without restrictions or&#xD;
             limitations (OHCA cohort only)&#xD;
&#xD;
          -  MI with performed coronary angiography (MI cohort only)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Temperature on admission &lt;30°C (OHCA cohort only)&#xD;
&#xD;
          -  On extracorporeal membrane oxygenation (ECMO) prior to return of spontaneous&#xD;
             circulation (OHCA cohort only)&#xD;
&#xD;
          -  Obvious or suspected pregnancy&#xD;
&#xD;
          -  Intracranial bleeding (OHCA cohort only)&#xD;
&#xD;
          -  Severe chronic obstructive pulmonary disorder (COPD) with long-term home oxygen&#xD;
             therapy&#xD;
&#xD;
          -  Clinical dementia diagnosis before the event&#xD;
&#xD;
          -  Inability to speak the local language well enough to complete the assessment without&#xD;
             assistance from an interpreter&#xD;
&#xD;
          -  Inability to meet for a face-to-face examination&#xD;
&#xD;
          -  Clinical Frailty Scale Index ≥8, indicating very severe frailty&#xD;
&#xD;
          -  Cardiac arrest before or in connection with MI (MI cohort only)&#xD;
&#xD;
          -  Active substance abuse&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Niklas Nielsen, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Lund University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gisela Lilja, PhD, OT</last_name>
    <role>Study Director</role>
    <affiliation>Lund University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tobias Cronberg, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Lund University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susanna Vestberg, PhD, Lic.Psych.</last_name>
    <role>Study Director</role>
    <affiliation>Lund University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Göteborg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Halmstad County Hospital</name>
      <address>
        <city>Halmstad</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsingborg Hospital</name>
      <address>
        <city>Helsingborg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skane University Hospital</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skane University Hospital</name>
      <address>
        <city>Malmö</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Essex Cardiothoracic Centre, Basildon and Thurrock University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Basildon</city>
        <state>Essex</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Wales, Cardiff and Vale University Health Board</name>
      <address>
        <city>Cardiff</city>
        <state>Wales</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 17, 2018</study_first_submitted>
  <study_first_submitted_qc>May 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2018</study_first_posted>
  <last_update_submitted>May 20, 2021</last_update_submitted>
  <last_update_submitted_qc>May 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuropsychology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Hypoxia-Ischemia, Brain</mesh_term>
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

